These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 34286553

  • 1. Phyllanthus niruri and Chrysanthellum americanum in association with potassium and magnesium citrates are able to prevent symptomatic episode in patients affected by recurrent urinary stones: A prospective study.
    Cai T, Tiscione D, Puglisi M, Malossini G, Ruggera L, Verze P, Arcaniolo D, Palmieri A.
    Arch Ital Urol Androl; 2021 Jun 28; 93(2):184-188. PubMed ID: 34286553
    [Abstract] [Full Text] [Related]

  • 2. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.
    Nishiura JL, Campos AH, Boim MA, Heilberg IP, Schor N.
    Urol Res; 2004 Oct 28; 32(5):362-6. PubMed ID: 15221244
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hibiscus extract, vegetable proteases and Commiphora myrrha are useful to prevent symptomatic UTI episode in patients affected by recurrent uncomplicated urinary tract infections.
    Cai T, Tiscione D, Cocci A, Puglisi M, Cito G, Malossini G, Palmieri A.
    Arch Ital Urol Androl; 2018 Sep 30; 90(3):203-207. PubMed ID: 30362679
    [Abstract] [Full Text] [Related]

  • 10. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial.
    Soygür T, Akbay A, Küpeli S.
    J Endourol; 2002 Apr 30; 16(3):149-52. PubMed ID: 12028622
    [Abstract] [Full Text] [Related]

  • 11. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 12. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, Suwantrai S, Noppawinyoowong C, Maskasame S, Sriboonlue P.
    J Med Assoc Thai; 2004 Mar 07; 87(3):255-63. PubMed ID: 15117041
    [Abstract] [Full Text] [Related]

  • 13. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Mar 07; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 14. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A, Esposito N, Castelnuovo C.
    Arch Ital Urol Androl; 2009 Sep 07; 81(3):188-91. PubMed ID: 19911683
    [Abstract] [Full Text] [Related]

  • 15. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis.
    Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A.
    J Urol; 1997 Dec 07; 158(6):2069-73. PubMed ID: 9366314
    [Abstract] [Full Text] [Related]

  • 16. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
    Butz M.
    Urologe A; 1982 May 07; 21(3):142-6. PubMed ID: 7048691
    [Abstract] [Full Text] [Related]

  • 17. Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
    Doizi S, Poindexter JR, Pearle MS, Blanco F, Moe OW, Sakhaee K, Maalouf NM.
    J Urol; 2018 Dec 07; 200(6):1278-1284. PubMed ID: 30036516
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia.
    Whalley NA, Meyers AM, Martins M, Margolius LP.
    Br J Urol; 1996 Jul 07; 78(1):10-4. PubMed ID: 8795392
    [Abstract] [Full Text] [Related]

  • 19. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment.
    Tungsanga K, Sriboonlue P, Futrakul P, Yachantha C, Tosukhowong P.
    Urol Res; 2005 Feb 07; 33(1):65-9. PubMed ID: 15565439
    [Abstract] [Full Text] [Related]

  • 20. Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence.
    Proietti S, Giannantoni A, Luciani LG, Sortino G, Graziotti P, Giusti G.
    Urolithiasis; 2014 Aug 07; 42(4):285-90. PubMed ID: 24972556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.